Your browser doesn't support javascript.
loading
Treatment for ovarian clear cell carcinoma with combined inhibition of WEE1 and ATR.
Chien, Wenwen; Tyner, Jeffrey W; Gery, Sigal; Zheng, Yueyuan; Li, Li-Yan; Gopinatha Pillai, Mohan Shankar; Nam, Chehyun; Bhowmick, Neil A; Lin, De-Chen; Koeffler, H Phillip.
Afiliación
  • Chien W; Department of Medicine, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, 8700 Beverly Boulevard, Los Angeles, CA, 90048, USA. chienw1@cshs.org.
  • Tyner JW; Knight Cancer Institute, Oregon Health & Science University, Oregon Health and Science University, 2720 S.W. Moody Avenue, Portland, OR, 97201, USA.
  • Gery S; Department of Medicine, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, 8700 Beverly Boulevard, Los Angeles, CA, 90048, USA.
  • Zheng Y; Clinical Big Data Research Center, Scientific Research Center, The Seventh Affiliated Hospital of Sun Yat-Sen University, Shenzhen, 518107, P. R. China.
  • Li LY; The Key Laboratory of Molecular Biology for High Cancer Incidence Coastal Chaoshan Area, Shantou University Medical College, Shantou, Guandong Province, P. R. China.
  • Gopinatha Pillai MS; Department of Medicine, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, 8700 Beverly Boulevard, Los Angeles, CA, 90048, USA.
  • Nam C; Center for Craniofacial Molecular Biology, University of Southern California, Los Angeles, CA, 90089, USA.
  • Bhowmick NA; Department of Medicine, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, 8700 Beverly Boulevard, Los Angeles, CA, 90048, USA.
  • Lin DC; Center for Craniofacial Molecular Biology, University of Southern California, Los Angeles, CA, 90089, USA.
  • Koeffler HP; Department of Medicine, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, 8700 Beverly Boulevard, Los Angeles, CA, 90048, USA.
J Ovarian Res ; 16(1): 80, 2023 Apr 22.
Article en En | MEDLINE | ID: mdl-37087441

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Ováricas / Proteínas Tirosina Quinasas / Adenocarcinoma de Células Claras / Proteínas de la Ataxia Telangiectasia Mutada Límite: Female / Humans País/Región como asunto: Asia Idioma: En Revista: J Ovarian Res Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Reino Unido

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Ováricas / Proteínas Tirosina Quinasas / Adenocarcinoma de Células Claras / Proteínas de la Ataxia Telangiectasia Mutada Límite: Female / Humans País/Región como asunto: Asia Idioma: En Revista: J Ovarian Res Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Reino Unido